Skip to main content
Aller à la page d’accueil de la Commission européenne (s’ouvre dans une nouvelle fenêtre)
français fr
CORDIS - Résultats de la recherche de l’UE
CORDIS

Structure, mechanism, and small-molecule inhibition of human and parasite oligosaccharyltransferases

Objectif

The evolution of multicellular eukaryotic organisms correlates with an enormous increase of N- glycosites and N-glycoproteins, which have essential roles in cell-cell communication, organ development, the immune system, and other key functions in ontogenesis. At the core of this process stands oligosaccharyltransferase (OST), the central enzyme in protein N-glycosylation. OST glycosylates proteins that contain short recognition sequons (N-X-S/T) by transferring a well-defined glycan from a glycolipid substrate. These reactions occur in the endoplasmic reticulum and precede protein folding because most sequons are no longer accepted by OST in the folded protein.
To address how one enzyme, OST, can accommodate and process a multitude of acceptor proteins, we will combine structure determination of OST complexes by cryo-EM, chemo-enzymatic substrate synthesis, in vitro and in vivo analyses of the N-glycosylation reaction and output, and molecular modelling in our experimental approach.
Our research strategy is guided by the evolution of OST itself: In contrast to human cells, eukaryotic parasites have reduced the complexity of their N-glycoproteomes. This simplification correlates with a reduced complexity of OST architecture, which contains fewer than the 8 subunits of human OST. We plan to determine the first structures of parasite OST enzymes and compare their in vitro activities to human OST.
Based on the structural and functional differences between parasitic and human OST, we will search for specific small-molecule inhibitors of OST as research tools or as therapeutics.
Our studies will provide insight into N-glycoproteome biogenesis, reveal the functional architecture of mammalian and parasite OST enzymes, and facilitate the development of small- molecule OST inhibitors. The tools and methodologies developed will also pave the way for novel biotechnological applications of N-glycoprotein and N-glycopeptide generation through enzymatic in vitro pipelines.

Champ scientifique (EuroSciVoc)

Mots‑clés

Programme(s)

Thème(s)

Régime de financement

HORIZON-ERC - HORIZON ERC Grants

Voir tous les projets financés dans le cadre de ce programme de financement

Appel à propositions

(s’ouvre dans une nouvelle fenêtre) ERC-2025-ADG

Voir tous les projets financés au titre de cet appel

Institution d’accueil

EIDGENOESSISCHE TECHNISCHE HOCHSCHULE ZUERICH
Contribution nette de l'UE
€ 2 499 966,00
Adresse
Raemistrasse 101
8092 Zuerich
Suisse
Région
Schweiz/Suisse/Svizzera Zürich Zürich
Type d’activité
Higher or Secondary Education Establishments
Liens
Coût total
Aucune donnée

Bénéficiaires (1)